Biological active metabolites from microalgae for healthcare and pharmaceutical industries: A comprehensive review

Tengku Nilam Baizura Tengku Ibrahim, Nur Azalina Suzianti Feisal, Noor Haziqah Kamaludin, Wai Yan Cheah, Vivien How, Amit Bhatnagar, Zengling Ma, Pau Loke Show

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Abstract

Microalgae are photoautotrophic microorganisms which comprise of species from several phyla. Microalgae are promising in producing a varieties of products, including food, feed supplements, chemicals, and biofuels. Medicinal supplements derived from microalgae are of a significant market in which compounds such as -carotene, astaxanthin, polyunsaturated fatty acids (PUFA) such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), and polysaccharides such as –glucan, are prominent. Microalgae species which are commonly applied for commercial productions include Isochrysis sp., Chaetoceros (Chlorella sp.), Arthrospira sp. (Spirulina Bioactive) and many more. In this present review, microalgae species which are feasible in metabolites production are being summarized. Metabolites produced by microalgae as well as their prospective applications in the healthcare and pharmaceutical industries, are comprehensively discussed. This evaluation is greatly assisting industrial stakeholders, investors, and researchers in making business decisions, investing in ventures, and moving the production of microalgae-based metabolites forward.

Original languageBritish English
Article number128661
JournalBioresource Technology
Volume372
DOIs
StatePublished - Mar 2023

Keywords

  • Biological active compounds
  • Healthcare
  • Metabolites
  • Microalgae
  • Pharmaceutical

Fingerprint

Dive into the research topics of 'Biological active metabolites from microalgae for healthcare and pharmaceutical industries: A comprehensive review'. Together they form a unique fingerprint.

Cite this